Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
OPERATING ACTIVITIES:
Net income (loss)	$ 68	$ 780
Adjustments to reconcile to net cash provided (used) by operating activities:
Depreciation and amortization	1,285	1,275
Provision (benefit) for deferred income taxes	52	268
Equity (earnings) losses	(236)	(260)
Distributions from unconsolidated affiliates	466	458
Gain on disposition of equity-method investments (Note 5)	0	(122)	[1]
Impairment of goodwill (Note 12)	187	0
Impairment of equity-method investments (Note 12)	938	186
Impairment of certain assets (Note 12)	0	76
Amortization of stock-based awards	39	44
Cash provided (used) by changes in current assets and liabilities:
Accounts receivable	(18)	159
Inventories	(33)	7
Other current assets and deferred charges	(15)	(10)
Accounts payable	(77)	(76)
Accrued liabilities	(286)	76
Other, including changes in noncurrent assets and liabilities	12	(159)
Net cash provided (used) by operating activities	2,382	2,702
FINANCING ACTIVITIES:
Proceeds from (payments of) commercial paper – net	40	(4)
Proceeds from long-term debt	3,898	736
Payments of long-term debt	(3,836)	(904)
Proceeds from issuance of common stock	9	10
Common dividends paid	(1,456)	(1,382)
Dividends and distributions paid to noncontrolling interests	(147)	(86)
Contributions from noncontrolling interests	5	32
Payments for debt issuance costs	(20)	0
Other – net	(12)	(11)
Net cash provided (used) by financing activities	(1,519)	(279)
INVESTING ACTIVITIES:
Capital expenditures (1)	(938)	(1,705)
Dispositions - net	(30)	(32)
Contributions in aid of construction	27	25
Purchases of businesses, net of cash acquired (Note 2)	0	(728)
Proceeds from dispositions of equity-method investments (Note 5)	0	485
Purchases of and contributions to equity-method investments	(150)	(361)
Other – net	9	(28)
Net cash provided (used) by investing activities	(1,082)	(2,344)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(219)	79
Cash and cash equivalents at beginning of year	289	168
Cash and cash equivalents at end of period	70	247
(1) Increases to property, plant, and equipment	(912)	(1,707)
Changes in related accounts payable and accrued liabilities	(26)	2
Capital expenditures (1)	(938)	(1,705)
Northeast JV [Member]
FINANCING ACTIVITIES:
Contributions from noncontrolling interests	$ 0	$ 1,330

[1] In April 2019, we sold our 50 percent equity-method interest in Jackalope for $485 million in cash, resulting in a gain on the disposition of $122 million.